Lineage Cell Therapeutics, Inc. (LCTX)
1.225
+0.02
(+1.24%)
USD |
NYAM |
Jun 09, 16:00
1.225
0.00 (0.00%)
After-Hours: 16:03
Lineage Cell Therapeutics SG&A Expense (Quarterly) : 5.084M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Curis, Inc. | 5.07M |
| Halozyme Therapeutics, Inc. | 57.88M |
| Agenus, Inc. | 6.86M |
| Amgen, Inc. | 1.602B |
| BioCryst Pharmaceuticals, Inc. | 94.55M |